HTR1A and Alzheimer disease: Compared to AD rats, those treated with 5-HT1A receptor antagonists and 5-HT2A receptor agonists showed significant biochemical improvements, including reduced levels of brain inflammation markers, oxidative stress indicators, and Aβ deposition [86].